Please refer to our letter dated November 8 2022 wherein we have intimated the schedule of Investors/ Analysts call on November 14 2022. In this connection we enclose herewith the presentation that would be used in the Investors / Analysts call on the Un-audited Financial Results of the Company for the Second quarter and half year ended September 30 2022.The presentation is also being uploaded in the following weblink of the Company.https://www.aurobindo.com/investors/disclosures-under-regulation-46/investor-meet/presentations/
Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Investor Presentation
November 12, 2022
Download PDF
Aurobindo Pharma
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month